Matthew Frederick LeFebvre

Title: Matthew Frederick LeFebvre: Innovator in Influenza Virus Research

Introduction

Matthew Frederick LeFebvre is a notable inventor based in Roseville, MN (US). He has made significant contributions to the field of virology, particularly in the development of mutant influenza virus vectors. With a total of 4 patents to his name, LeFebvre's work is paving the way for advancements in vaccine technology.

Latest Patents

LeFebvre's latest patents focus on compositions and methods related to mutant viruses, specifically mutant influenza viruses. These patents disclose a mutant M2 sequence that is useful in immunogenic compositions, such as vaccines. The mutant viruses are designed to deliver antigens to a subject, thereby inducing an immune response to the antigen. Additionally, the patents cover methods, compositions, and cells for propagating these viral mutants, as well as methods, devices, and compositions related to vaccination.

Career Highlights

LeFebvre is currently associated with Flugen, Inc., a company dedicated to innovative solutions in the field of influenza research. His work at Flugen has been instrumental in advancing the understanding and treatment of influenza viruses.

Collaborations

LeFebvre collaborates with esteemed colleagues, including Yasuko Hatta and Pamuk Bilsel, who contribute to the research and development efforts at Flugen, Inc.

Conclusion

Matthew Frederick LeFebvre's innovative work in the field of influenza virus research highlights his commitment to improving vaccine technology. His contributions are essential in the ongoing fight against viral infections, and his patents reflect a significant advancement in immunology.